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Abstract
The genus Salmonella includes many pathogens of great medical and veterinary importance. Bacteria belonging to this
genus are very closely related to those belonging to the genus Escherichia. lacZYA operon and lacI are present in Escherichia
coli, but not in Salmonella enterica. It has been proposed that Salmonella has lost lacZYA operon and lacI during evolution. In
this study, we have investigated the physiological and evolutionary significance of the absence of lacI in Salmonella enterica.
Using murine model of typhoid fever, we show that the expression of LacI causes a remarkable reduction in the virulence of
Salmonella enterica. LacI also suppresses the ability of Salmonella enterica to proliferate inside murine macrophages.
Microarray analysis revealed that LacI interferes with the expression of virulence genes of Salmonella pathogenicity island 2.
This effect was confirmed by RT-PCR and Western blot analysis. Interestingly, we found that SBG0326 of Salmonella bongori
is homologous to lacI of Escherichia coli. Salmonella bongori is the only other species of the genus Salmonella and it lacks the
virulence genes of Salmonella pathogenicity island 2. Overall, our results demonstrate that LacI is an antivirulence factor of
Salmonella enterica and suggest that absence of lacI has facilitated the acquisition of virulence genes of Salmonella
pathogenicity island 2 in Salmonella enterica making it a successful systemic pathogen.
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Introduction
The genus Salmonella includes Gram-negative facultative intra-
cellular pathogens that infect reptiles, birds and mammals. This
genus includes two species, viz. Salmonella bongori (S. bongori) and
Salmonella enterica (S. enterica). S. enterica is subdivided into many
subspecies and serovars. In humans, Salmonella enterica serovar
Typhi causes typhoid fever and serovars Typhimurium and
Enteritidis cause food poisoning.
The virulence of S. enterica can be attributed largely to
horizontally acquired genomic islands termed Salmonella pathoge-
nicity islands (SPI) [1,2]. Among them, Salmonella pathogenicity
island 2 (SPI-2) imparts S. enterica an ability to cause systemic
infection. SPI-2 is 40 kb in size and can be divided into two distinct
parts. One part is 25 kb in size and encodes a type three secretion
system(TTSS).Thispart isessentialforthesystemicvirulenceandis
present in S. enterica, but absent in S. bongori. The other part is 15 kb
in size and is not essential for the systemic virulence of S. enterica.
This region encodes the tetrathionate reductase involved in
anaerobic respiration and is present in both S. bongori and S. enterica
[3–5]. Evolutionary significance of S. bongori not having the 25 kb
part and S. enterica having both parts of SPI-2 is not clear.
Bacteria belonging to the genus Salmonella are closely related to
those belonging to the genus Escherichia and they have diverged
from a common ancestor about 100 million years ago [6]. Despite
their close relationship, E. coli has more than 800 genes that are
absent in the S. enterica genome and more than 1,100 S. enterica
genes lack their homologues in E. coli [7]. The region containing
lacI and the lac operon is one such locus and is present in E. coli,
but absent in S. enterica. Thus, E. coli is a lactose fermenter, whereas
S. enterica is a lactose non-fermenter. Nonetheless, diseases caused
by lactose-fermenting Salmonella have been reported occasionally
and they harbor genes responsible for lactose fermentation in
extra-chromosomal genetic elements like plasmids [8–12].
The lac operon consists of three genes, lacZ, lacY and lacA which
encode b-galactosidase, lactose permease and a transacetylase,
respectively. lacI which encodes lac repressor (LacI) is located
adjacent to lacZYA, but is transcribed as a separate message. LacI
binds to the operator region of the lac operon and prevents the
transcription of lacZYA genes unless lactose is present in the
environment [13]. Expression of the lac operon when lactose is
absent in the environment is costly for the bacteria [14] and LacI
prevents such unnecessary expression of the lac operon. Consti-
tutive expression of the lac operon lowers the fitness of the bacteria
when lactose is not present in the environment [15,16]. Therefore,
LacI is very important to maintain the fitness of the bacterium that
harbors the lac operon. None of the lactose-fermenting Salmonella
strains (see above) are reported to harbor LacI, except S. Typhi
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5789strain ST-2 which harbors a mutant LacI with a diminished
repressing ability [12].
It has been proposed that S. enterica has lost lac region (lacI and
lacZYA) during evolution [17]. Many serovars of S. enterica are
intestinal pathogens of mammals and like E. coli they are exposed
to lactose in the mammalian gut. Then, why has S. enterica lost the
ability to ferment lactose? So far, there are no studies which
address this issue. In this study, we have investigated the
physiological and evolutionary significance behind the loss of (or
absence of) lac region in S. enterica. We have chosen LacI for this
study because it is very important for a bacterium harboring the lac
operon to have lacI as unnecessary expression of the lac operon
lowers the fitness of the bacteria harboring it [15,16]. Our study
demonstrates that the expression of LacI in S. enterica reduces its
virulence and suggests that lack of lacI has facilitated S. enterica to
gain systemic virulence via SPI-2.
Results
We used pTrc99A plasmid that harbors lacI gene to express
LacI in S. enterica [18]. We deleted lacI from this plasmid to get
pTrc(-LacI) plasmid and also we mobilized lacI along with its
promoter from pTrc99A to pBR322 to get pBR322(+LacI). All
these plasmids, viz. pTrc99A, pTrc(-LacI), pBR322 and
pBR322(+LacI), were individually transformed into the wild-type
(WT) strain of S. enterica serovar Typhimurium (S. Typhimurium).
Expression of lacI in the strains harboring pTrc99A and
pBR322(+LacI) was confirmed by RT-PCR and Western blot
(Fig. S1 A and C). Growth of all these strains in Luria broth (LB)
and M9 minimal medium were comparable to that of the parental
WT strain (data not shown). Both pTrc99A and pBR322 have
colE1 replicon and thus, have low to moderate (fifteen to twenty)
copy numbers [19].
S. enterica expressing LacI exhibits reduced virulence in
murine typhoid fever model
Most of the known S. enterica serovars are pathogenic to one or
the other vertebrate species. We were interested to know the effect
of LacI on the virulence of S. enterica. We used murine typhoid
fever model for this purpose. Mice were infected intra-peritoneally
with S. enterica strains harboring different plasmids (see above) and
infected mice were monitored for survival for 3 months. All the
mice infected with the WT strain and strains harboring either
pTrc(-LacI) or pBR322 (plasmids without lacI) were dead within 5
days of infection. Interestingly, 60% of the mice infected with
strains harboring either pBR322(+LacI) or pTrc99A (plasmids
expressing lacI) survived and did not succumb to the infection even
after 3 months of infection (Fig. 1A).
Then, we examined the bacterial load in infected mice after 3
days of infection. We observed about 2 to 3 log order reduction in
the bacterial load in spleen and mesenteric lymph node of the mice
infected with strains harboring either pTrc99A or pBR322(+LacI)
when compared to the organs of the mice infected with the WT
strain (P,0.01). However, the bacterial load in spleen and
mesenteric lymph node of the mice infected with strains harboring
either pBR322 or pTrc(-LacI) were not different from those of the
mice infected with the WT strain (P.0.05) (Fig. 1 B and C). These
findings clearly show that LacI suppresses the virulence of S.
enterica. LacI-dependent attenuation of Salmonella was also observed
when the infection was done via intra-gastric route (Figure S2).
There is a possibility that plasmids may get lost from bacteria
during infection and in such case, selecting bacteria on medium
containing antibiotic will underestimate the bacterial load. To rule
out such possibility, the organ homogenate was plated separately
on medium with or without antibiotics. We observed that presence
of antibiotic in the medium does not cause any change in the
bacterial load estimation indicating that bacteria does not lose
plasmid during infection.
To further confirm the effect of LacI on the virulence of S.
enterica, we determined the competitive indices (CI) of strains
expressing LacI with respect to the WT strain. Determination of
CI is a very sensitive assay that compares the virulence of different
strains [20]. For this assay, we used the WT strain constitutively
expressing green fluorescent protein (GFP) to enable us to
distinguish colonies of WT bacteria from the colonies of other
strains on LB agar plate. The presence of GFP did not show any
significant effect on the virulence of the WT strain
(CI=1.2260.24; P.0.05). The CI values of strains harboring
either pBR322(+LacI) or pTrc99A, determined in both spleen and
mesenteric lymph node, were significantly (P,0.001) lesser than
those of strains harboring either pBR322 or pTrc(-LacI) (Fig. 2).
This result unequivocally demonstrates that LacI suppresses the
virulence in S. enterica.
S. enterica expressing LacI cannot proliferate inside
murine macrophages
Our next aim was to understand how LacI is suppressing the
virulence of S. enterica. To address this, we investigated the effect of
LacI on the ability of S. enterica to multiply inside macrophages.
Ability to multiply inside host macrophages is vital for the
virulence of S. enterica [21]. We observed that strains harboring
either pBR322(+LacI) or pTrc99A were unable to proliferate
inside RAW 264.7 cells, a murine macrophage-like cell line. In
contrast, proliferation of strains harboring either pTrc(-LacI) or
pBR322 inside these macrophages were comparable to that of the
WT strain (Fig. 3A and B). These finding illustrates that LacI
suppresses the ability of S. enterica to multiply inside host
macrophages and explains, at least in part, why S. enterica
expressing LacI is less virulent. Nevertheless, LacI expression did
not affect the entry of bacteria into epithelial (HeLa) cells as
demonstrated by an invasion assay (Figure S3).
Our next aim was to investigate the mechanism of action of
LacI that leads to the above observed effects in S. enterica; is DNA
binding property of LacI responsible for these effects? To address
this issue, we used isopropyl-b, D-thiogalactoside (IPTG). IPTG
binds with high affinity to LacI and lowers its affinity for the
operator DNA, the natural target of LacI [22]. However, IPTG
does not affect the binding of LacI to non-operator DNA [23,24].
Interestingly, LacI expressing strains [harboring either pTrc99A or
pBR322(+LacI)] did not show any defect in their ability to
multiply inside macrophages cultured in the presence of 10 mM
IPTG. Proliferation of all the strains, viz. S. enterica having either
pTrc99A or pTrc(-LacI) or pBR322 or pBR322(+LacI) were
similar to that of the WT strain inside macrophages (Fig. 3C and
D). DssaV, a mutant strain defective in secretion by the SPI-2 type
three secretion system (TTSS), was used as positive control
because SPI-2 encoded TTSS is essential for S. enterica to
proliferate inside host macrophages [5]. The phenotype of DssaV
strain was unaffected by IPTG (Fig. 3B and D).
This result clearly demonstrates that IPTG abolishes the
inhibitory effect of LacI on the ability of S. enterica to multiply
inside host macrophages. In addition, this result suggests that this
inhibitory effect of LacI may be due to its binding to operator
DNA and also it rules out the possible role of binding of LacI to a
non-operator DNA sequence in this effect. This result also shows
that LacI is indeed expressed in S. enterica harboring either
pTrc99A or pBR322(+LacI) because the effect of IPTG is due to
its binding with high affinity to LacI protein.
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PLoS ONE | www.plosone.org 3 June 2009 | Volume 4 | Issue 6 | e5789Figure 2. S. enterica expressing LacI are less competitive with respect to the WT strain. Mice (n=5 in each case) were infected intra-
peritoneally with a mixture of the WT strain and the indicated strain at 1:1 ratio (total 10
3 bacteria/mouse). After 3 days, CI values for all the strains
were calculated with respect to the WT strain. CI values determined in spleen (A) and mesenteric lymph node (B) are plotted. Horizontal lines indicate
mean values. Only four CI values are shown for the strain harboring pTrc99A in spleen and for the strain harboring pBR322(+LacI) in mesenteric lymph
node as the fifth CI values were zero in both cases. Student’s t-test was used to calculate the statistical significance. Graphs are representatives of two
independent experiments.
doi:10.1371/journal.pone.0005789.g002
Figure 1. S. enterica expressing LacI shows attenuated virulence in vivo. (A) Survival plots of mice (n=5 in each case) intra-peritoneally
infected with S. enterica harboring different plasmids (10
4 bacteria per mouse). Survival of mice infected with S. enterica expressing LacI [pTrc99A and
pBR322(+LacI)] were compared to that of mice infected with the WT strain to calculate the statistical significance (P=0.0023 for both the strains)
using Logrank test. Bacterial load in (B) spleen and (C) mesenteric lymph node of mice (n=5 in each case) intra-peritoneally infected (for 3 days) with
S. enterica harboring different plasmids (10
3 bacteria/mouse) are plotted in (B) and (C). The bacterial loads in organs of mice infected with
experimental strains were compared to those of mice infected with the WT strain to calculate statistical significance by student’s t-test. Horizontal
lines in (B) and (C) indicate mean values. Graphs are representatives of at least two independent experiments.
doi:10.1371/journal.pone.0005789.g001
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responsible for its effect on the virulence of S. enterica
In E. coli, LacI binds to the operator sequence present in the lac
operon [25]. Mutating Gln
60 to Gly and inserting three extra glycines
after 60
th amino acid of LacI abolishes its ability to bind to the
operator sequence without affecting its folding, assembly and inducer
(IPTG) -binding property. However, the ability of this mutant
LacI(Gly
60+3) to bind to a non-operator DNA sequence is similar to
that of the wild-type LacI [26]. We utilized this mutant LacI to
investigate whether operator-binding property of LacI is responsible
for its effect on the virulence of S. enterica. To our surprise, mice
infected with S. enterica expressing LacI(Gly
60+3)s u r v i v e dl o n g e rt h a n
those infected with the WT strain (Fig. 4A). Four out of five mice
infected with S. enterica expressing LacI(Gly
60+3) survived for more
than 3monthsafterinfectionanddid not succumbto infection. There
were no detectable bacteria in the organs of mice infected with S.
enterica expressing LacI(Gly
60+3) after 3 days of infection (Fig. 4B). In
addition, S. enterica expressing LacI(Gly
60+3) could not proliferate
inside macrophages (Fig. 4C). Our searchfor the presence of operator
sequence in S. Typhimurium genome (gi: 16763390) using genomic
BLAST program (BLASTN 2.2.18+) revealed that there is no
sequence that is significantly similar (expect value,10) to the
operator sequence (59-tgttgtgtggaattgtgagcggataacaatttcacacagg-39).
These results clearly demonstrate that the effect of LacI on the
virulence of S. enterica is independent of its ability to bind to the
operator sequence.
S. enterica expressing LacI is sensitive to mice serum
Pathogenic bacteria like S. enterica that are capable of causing
systemic disease are resistant to serum-mediated killing and this
Figure 3. Expression of LacI in S. enterica suppresses its ability to proliferate inside murine macrophages. RAW-264.7 cells were infected
with different strains as indicated at a MOI of 1:1 in the absence (A and B) or presence (C and D) of 10 mM IPTG. In all experiments, fold multiplication
of S. enterica inside RAW 264.7 cells was calculated by dividing the intracellular bacterial load at 16 h by the intracellular bacterial load at 2 h. The bars
represent mean fold-multiplication6standard error. Fold-multiplication of different strains were compared with that of the WT strain to calculate the
P value using Student’s t-test. Graphs shown are representatives of at least two independent experiments done in triplicates in each case.
doi:10.1371/journal.pone.0005789.g003
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growth of S. enterica harboring pTrc99A was significantly diminished
in mouse serum (Fig. 5).S. enterica expressing LacI thus appears to be
sensitive to serum-mediated killing; this might also contribute to the
diminished virulence of S. enterica expressing LacI.
LacI inhibits the expression of SPI-2 inside macrophages
Our next aim was to find out the possible targets of LacI in S.
enterica. We used microarray technique for this purpose. Micro-
array expression profiling was done using RNA isolated from the
WT strain and the strains harboring either pTrc99A or pTrc(-
LacI) plasmids during mid-log phase growth in M9 minimal
medium. The genes whose expression was affected in the strain
harboring pTrc99A but not in the strain harboring pTrc(-LacI)
were taken into consideration. We found 75 genes that were
significantly down-regulated and 147 genes that were significantly
up-regulated (.2-fold and P,0.02) in the strain harboring
pTrc99A (Table S1 and Table S2). Among them, we looked for
the genes that can influence the virulence of S. enterica. To our
interest, 4 genes (ssaK, ssaJ, ssrA and orf245) belonging to SPI-2
and phoP were down-regulated in the strain harboring pTrc99A
but not in the strain harboring pTrc(-LacI). Both SPI-2 and PhoP
are essential for the virulence of S. enterica [3,28]. This result
encouraged us to look for the expression profile of these genes in
the strain expressing LacI inside macrophages.
In addition to these genes, microarray analysis showed up-
regulation of some flagella-related genes (fliB, fliC and fliT), genes
involved in chemotaxis (cheZ, cheY, cheB and cheW) and genes
belonging to SPI-1 (sprB, prgK, spaP, spaO and invJ). We did not
pursue these genes further because up-regulation of these genes
does not explain attenuation of virulence in S. enterica.
The expression profile of SPI-2 genes in the strain harboring
pTrc99A inside macrophages was investigated using RT-PCR.
RNA was isolated from intracellular bacteria and subjected for
reverse transcription followed by PCR. We chose three virulence
genes, viz. ssaK, sseB and spiC which represent three different
operons of the 25 kb part of SPI-2 that encodes a TTSS.
Expression of ssaK, sseB and spiC was reduced in the strain
harboring pTrc99A inside macrophages. This reduction was not
observed in the strain harboring pTrc(-LacI) indicating that LacI
interferes with the expression of these genes. However, the
expression of phoP was unaffected (Fig. 6A). These results were
confirmed using quantitative real-time PCR analysis (Fig. S4).
To further confirm the effect of LacI on SPI-2 expression, we
looked at SseB protein level in intracellular bacteria recovered
from macrophages by Western blotting. We observed a remark-
able reduction in SseB protein level in the strain harboring
pTrc99A but not in the strain harboring pTrc(-LacI) inside
macrophages (Fig. 6B). Expression of SPI-2 can be induced in vitro
by using F medium [29]. This medium mimics intra-phagosomal
environment as it is low in magnesium and phosphorous and
acidic in pH. When grown in F medium for 2 h, there was
significant decrease in the SseB protein level in the strain
harboring pTrc99A but not in the strain harboring pTrc(-LacI)
(Fig. 6C).
These results unequivocally demonstrate that LacI interferes
with the expression of SPI-2 genes inside macrophages explaining,
at least in part, why S. enterica expressing LacI are unable to
proliferate inside macrophages and are attenuated in virulence in
vivo. As some of the SPI-2 mutants are shown to be sensitive to
serum mediated killing [30], this result also explains the serum
sensitivity of S. enterica expressing LacI.
SBG0326 of S. bongori is homologous to lacI
S. bongori, the only other Salmonella species, is found as a
commensal of cold-blooded animals and it cannot cause systemic
infections in mammals. 25 kb region of SPI-2 that encodes TTSS
is absent in S. bongori, but is present in S. enterica [5]. This region is
essential for the systemic virulence of S. enterica. These facts
prompted us to look for the presence of lacI homologue/s in S.
bongori genome. Interestingly, we observed that SBG0326 of S.
bongori is homologous to lacI of E. coli. The predicted amino acid
sequences of protein encoded by SBG0326 and LacI share 77%
identity and 88% similarity (Fig. 7A). However, we did not find
any transcript corresponding to lacI in S. bongori suggesting that
SBG0326 is probably a pseudogene (Fig. S1 A and B).
Our search also revealed that SBG0324 of S. bongori is
homologous to lacZ of E. coli. The predicted amino acid sequences
of protein encoded by SBG0324 and LacZ share 79% identity and
87% similarity. There were no genes that are homologous to lacY
and lacA in S. bongori genome.
We observed that prpE and hemB are contiguous in S. enterica.
However, these two genes are separated by four genes in S. bongori
two of which are SBG0324 (lacZ) and SBG0326 (lacI). In E. coli,
Figure 5. Sensitivity of S. enterica expressing LacI to mouse
serum. Bacteria were grown in 96-well plates along with mouse serum
as described in Materials and Methods for 4 h. Fold-replication was
calculated by dividing the number of bacteria recovered after 4 h by the
number of bacteria in the inoculum. Graph shown is a representative of
three independent experiments done with triplicate samples.
doi:10.1371/journal.pone.0005789.g005
Figure 4. Ability of LacI to bind to the operator sequence is not responsible for its effect on the virulenceof S. enterica. (A) Survival
plots of mice (n=5 in each case) intra-peritoneally infected (10
4 bacteria/mouse) with S. enterica expressing LacI(Gly
60+3), a mutant of LacI that cannot
bind to the operator sequence. Logrank test was used to calculate statistical significance. (B) Bacterial load in spleen and mesenteric lymph node of
mice (n=4 in each case) intra-peritoneally infected (for 3 days) with S. enterica expressing LacI(Gly
60+3) (10
3 bacteria/mouse). Horizontal lines indicate
mean values. (C) Intracellular multiplication of S. enterica expressing LacI(Gly
60+3) in RAW 264.7 cells. The bars represent mean fold-
multiplication6standard error. Student’s t-test was used to calculate P value. Graphs shown are representatives of at least two independent
experiments.
doi:10.1371/journal.pone.0005789.g004
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PLoS ONE | www.plosone.org 8 June 2009 | Volume 4 | Issue 6 | e5789Figure 7. SBG0326 of S. bongori is homologous to lacI of E. coli. (A) Alignment of predicted amino acid sequences of SBG0326 and LacI (E. coli
K12). Both of them share 77% identity and 88% similarity. Identical residues are underlined. (C) Schematic diagram showing organization of prpE to
hemB locus in S. bongori, S. Typhimurium and E. coli (K12). Each arrow represents indicated gene. Genes belonging to lac region are shown in darker
shade. In case of S. bongori and S. Typhimurium, the names of the homologous genes in E. coli are given below the arrows. Arrows are not to scale.
doi:10.1371/journal.pone.0005789.g007
Figure 6. LacI interferes with SPI-2 expression. (A) The effect of LacI on the expression of virulence genes inside macrophages was analyzed by
RT-PCR. cDNA was synthesized from the RNA isolated from intracellular bacteria and ssaK, sseB, spiC (representatives from SPI-2 island) and phoP were
amplified by PCR. (B) Analysis of SseB expression by Western blot using total protein extracted from intracellular bacteria. (C) Analysis of SseB
expression by Western blot using total protein extracted from bacteria grown in SPI-2-inducing (F medium) medium or LB for 2 h. Ribosomal
recycling factor (Rrf) served as internal control. Results are representatives of at least two independent experiments.
doi:10.1371/journal.pone.0005789.g006
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operon and lacI (Fig. 7B). These observations suggest that S. bongori
has partially lost the lac region, whereas S. enterica has lost it
completely.
Discussion
The evolution of bacterial pathogens from their nonpathogenic
ancestors is an exciting saga which involves many kinds of
fascinating genetic events. This is central to the understanding of
both the origin of infectious diseases and the emergence of new
pathogens. Some bacteria have horizontally acquired genetic
elements encoding virulence factors. For example, Salmonella has
manyhorizontallyacquired pathogenicityislands[1].Insome cases,
virulence results from allelic differences in homologous genes. For
example, genetic variation of fimH, a gene that encode adhesin of
type 1 fimbriae, is observed in nonpathogenic and uropathogenic E.
coli [31]. Some bacteria have selectively inactivated genes that are
no longer compatible with the pathogenic lifestyle of the bacteria
either by point mutation, insertion, or deletion. Such genes are
called ‘antivirulence genes’ [32]. For example, cadA and ompT are
absent in Shigella, but are present in nonpathogenic E. coli.
Introduction of either cadA or ompT attenuates virulence in Shigella
[33,34]. zirTS, grvA and pcgL are the antivirulence genes reported in
S. enterica [35–37]. However, all these genes are present in S. enterica
and modulate its virulence. So far, there is no report of an
antivirulence gene of S. enterica that has been lost during evolution.
Our study unequivocally demonstrates that lacI is an antivirulence
gene of S. enterica which has been lost from it, but present in closely
related S. bongori and E. coli.
We recognize the fact that the observed remarkable inhibitory
effect of LacI on the virulence of S. enterica may be an exaggerated
effect of LacI expression using plasmids having low to moderate
copy numbers (fifteen to twenty). pTrc99A plasmid has operator
region that can quench a part of LacI which reduces the amount
of free LacI and decreases the effect of copy number of the plasmid
on freely available LacI. Nevertheless, a slight inhibitory effect on
the expression of virulence gene is sufficient to drive a genetic trait
(if dispensable) towards negative selection.
Plasmids lacking LacI [pTrc99(-LacI) and pBR322] express
beta-lactamase and tetracycline resistance proteins which are
foreign to Salmonella, but they do not affect the virulence of S.
enterica. Moreover, constitutive expression of green fluorescent
protein also did not affect the virulence of S. enterica. Therefore, the
effect of LacI on the virulence of S. enterica is unlikely to be just an
artifact caused by the expression of a foreign protein.
There are two possibilities by which LacI can inhibit the
virulence of S. enterica: either by binding to DNA or by binding to a
protein. With respect to DNA binding, IPTG and Gly
60+3
mutation in LacI have same effect on the function of LacI. Both
of them inhibit the LacI binding to the operator DNA without
affecting its binding to non-operator sequence. IPTG could reverse
the inhibitory effect of LacI on the ability of S. enterica to proliferate
inside macrophages, whereas S. enterica expressing LacI mutant
(Gly
60+3) was unable to proliferate inside macrophages. These
results indicate that the effect of LacI on the virulence of S. enterica
is not because of its DNA binding property. The other possibility is
the binding of LacI to a protein. As LacI can form homodimer and
homotetramer, there is a possibility of LacI forming heterodimer
or heterotetramer with other transcriptional factors or any proteins
present in S. enterica and IPTG might inhibit such protein-protein
interactions. All these possibilities need to be investigated.
Our study demonstrates that the antivirulence property of LacI
in S. enterica is, at least in part, because of its interference with the
expression of SPI-2. Acquisition of SPI-2 by S. enterica is a
landmark event in the evolution of Salmonella. SPI-2 has enabled S.
enterica to survive and multiply inside macrophages resisting their
antimicrobial activities [38,39]. This ability is essential for S.
enterica to cause systemic infection [3,5]. Thus, acquisition of
virulence genes of SPI-2 has made it possible for S. enterica to
extend its niche beyond intestine, whereas absence of the same has
made S. bongori a mere commensal of cold-blooded animals. Based
on these facts and our results, we propose that presence of
SBG0326 (lacI) has probably hindered the acquisition of virulence
genes of SPI-2 in S. bongori, whereas absence of lacI has facilitated
the same in S. enterica making it a successful systemic pathogen.
Thus, lacI has played a remarkable role in the evolution of
virulence in Salmonella.
Materials and Methods
Bacterial strains, plasmids and culture conditions
Salmonella enterica serovar Typhimurium strain NCTC 12023
was used as wild-type (WT) in all experiments. This was the
parental strain for all other strains. DssaV and S. bongori IH4 strains
were kind gifts from Prof. Michael Hensel. Various plasmids used
in this study are listed in Table S3. pTrc(-LacI) was constructed by
digesting pTrc99A plasmid with BssHII to remove 872 nucleotide
region encoding LacI and self-ligating the remaining plasmid. The
deleted region included the promoter of lacI. lacI, including its
promoter region, of pTrc99A was mobilized into EcoRI and
HindIII sites of pBR322 to get pBR322(+LacI) plasmid. Primers
used for constructing different plasmids are listed in Table S4. All
plasmids were individually transformed to WT S. enterica. Bacteria
were routinely cultured in Luria broth (LB) at 37uC. Optical
density of the bacterial culture at 600 nm was measured every
hour till stationary phase reached in order to monitor the growth
of all the strains in LB or M9 minimal medium.
Mice infections
All procedures with animals were carried out in accordance
with institutionally approved protocols. Six- to eight-week-old
BALB/c mice were infected intra-peritoneally with S. enterica in all
the experiments. A dose of 10
3 bacteria per mouse was used to
investigate the bacterial load in spleen and mesenteric lymph
node. After 3 days of infection, spleen and mesenteric lymph node
of infected mice were harvested and homogenized. Bacteria were
enumerated after plating a dilution series onto LB agar. A dose of
10
4 bacteria per mouse was used to follow the survival of the
infected mice for 3 months. To calculate the competitive indices
(CI) of S. enterica harboring different plasmids, mice were infected
with equal amounts of WT S. enterica constitutively expressing
green fluorescent protein (pFPV25.1) and the experimental strain
(a ratio of 1:1). A total of 10
3 bacteria per mouse were inoculated.
After 3 days, spleen and mesenteric lymph node were harvested,
homogenized and the homogenate was plated onto LB agar.
Bacterial colonies with (WT strain) or without (experimental
strains) green fluorescence were enumerated. The CI was defined
as the ratio of the experimental strain to the WT strain recovered
from the mice divided by their ratio in the initial inoculum [20].
Presence of green fluorescent protein did not affect the virulence of
S. enterica.
Serum sensitivity assay
Blood collected by retro-orbital bleeding of mice was used to
extract the serum. Healthy, Six- to eight-week-old BALB/c mice
(that were to be sacrificed for some other purpose) were used for
retro-orbital bleeding. Bacteria in exponential phase were seeded
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4 bacteria per
well in 50 ml of a solution containing 0.5% tryptone and 0.5%
sodium chloride. 50 ml of mouse serum was added to each well
and incubated at 37uC in shaking conditions for 4 h. The samples
were then plated at different dilutions on LB plates. Fold
multiplication was calculated by dividing the number of bacteria
recovered after 4 h by the number of bacteria in the inoculum.
Eukaryotic cell culture and intracellular proliferation
assays
RAW 264.7 cells were grown routinely in Dulbecco’s Modified
Eagle’s Medium (DMEM; Sigma-Aldrich, USA) supplemented
with 10% fetal calf serum (Sigma-Aldrich, USA) at 37uCi n5 %
CO2. RAW 264.7 cells (3610
5 per well) were seeded in 24-well
plates 12 to 24 h prior to infection. These cells were infected with
overnight culture of a specific strain of S. enterica as described
earlier at a multiplicity of infection (MOI) of 1:1 [40]. To check
the expression of SPI-2 genes by RT-PCR and western blot, an
MOI of 50:1 was used. Fold intracellular multiplication was
calculated by dividing the intracellular bacterial load at 16 h by
the intracellular bacterial load at 2 h.
Microarray analysis
The WT strain and the strains harboring either pTrc99A or
pTrc(-LacI) were grown in M9 minimal medium for 9 h (mid-log
phase). After 9 h, total RNA was isolated from equal number of
bacteria of each strain using ‘RNeasy Mini Kit’ (QIAGEN, USA).
‘RNAprotect Bacteria Reagent’ (QIAGEN, USA) was used to
stabilize RNA before bacterial cells were lysed. The quality of the
RNA was checked using ‘Agilent - 2100 Bioanalyzer’ (Agilent
Technologies, USA). RNAwasamplifiedusing ‘MessageAmp
TMII-
Bacteria RNA Amplification kit’ (Ambion, USA) and labeled using
‘Low Input RNA amplification kit’ (Agilent Technologies, USA).
Hybridization was done using ‘In situ Hybridization kit’ (Agilent
Technologies, USA). Dye-swap was included in the hybridization
plan. Hybridization plan was as follows: WTCy3 vs. pTrc99ACy5,
WTCy5 vs. pTrc99ACy3,W T Cy3 vs. pTrc(-LacI)Cy5,W T Cy5 vs.
pTrc(-LacI)Cy3. Slides were scanned at 5 m resolution using Agilent
scanner. Automated feature extraction was done using Agilent’s
Feature Extraction Software. Analysis of feature extracted data was
done using Agilent’s GeneSpring GX V 7.3.1 software. The
normalization was done using GeneSpring GX using the recom-
mended Per Chip and Per Gene Data Transformation. Genes with
ratio of 2 and above were considered as up-regulated and with ratio
0.5 and below were considered down-regulated. P value was
calculatedbyGeneSpringGXforeachgene onthe basisofreplicate
probes to indicate statistical significance. P value less than 0.02 was
taken as statistically significant. Raw data of microarray experiment
is provided in Table S5. All microarray data reported in the
manuscript is described in accordance with MIAME guidelines and
the data from the experiments are deposited in GEO (accesssion no.
GSE15950 and GPL8520).
Extraction of bacterial RNA and protein from infected
cells
Twelve hours after infection, RAW 264.7 cells were lysed on ice
by incubating for 30 min in 0.1% SDS, 1% acidic phenol, and
19% ethanol in water. Bacteria were isolated from the lysate by
centrifugation; RNA and total protein were extracted from the
pellet using TRI reagent (Sigma-Aldrich, USA) according to the
manufacturer’s protocol. In each case, bacteria were recovered
from two 6-well plates of infected RAW 264.7 cells and infected
cells were pooled to isolate RNA and protein.
RT-PCR
RNA was extracted from an overnight bacterial culture to check
the expression of lacI and from intracellular bacteria (isolated from
RAW 264.7 cells) to check the expression of SPI-2 genes. RNA (2 mg)
was treated with RNase-free DNase (Fermentas, USA) and then
reverse transcribed using a reverse transcription system (Promega,
USA). The cDNA thus generated was amplified using specific
primers designed for lacI, phoP, ssaK, sseB, spiC, rpoD and 16S rRNA.
The nucleotide sequences of all primers are given in Table S4.
Western blot
To check the expression of SPI-2, total protein was extracted
from intracellular bacteria (isolated from RAW 264.7 cells) and
also from bacteria grown in F or LB medium for 2 h. The F
medium was prepared as described previously [29]. Protein was
electrophoresed and transferred to a polyvinylidene difluoride
membrane (Millipore, USA). The membrane was then probed
with SseB or Rrf antibody (a kind gift from Prof. Hensel and Prof.
Varshney, respectively) and respective horse radish peroxidase-
(HRP) conjugated secondary antibody (Bangalore Genei, India).
Immune complexes were detected using an enhanced chemilumi-
nescence reagent (PerkinElmer, USA).
Bioinformatic analysis
The complete genome sequence of S. bongori 12419 ATCC
43975 available in Welcome Trust Sanger Institute website
(http://www.sanger.ac.uk/Projects/Salmonella/) and the nucleo-
tide sequences of lacI and lacZYA genes of E. coli K12 were used to
search for the presence of lac region in S. bongori; ‘BLAST 2
sequences’ tool was used for this analysis [41]. ExPASy-Translate
tool was used to predict amino acid sequences [42]. ClustalW
program was used for amino acid sequence alignment [43].
Statistical methods
Logrank test was used to analyze the survival curves of mice
infected with different strains of S. enterica. Student’s t-test was used
to analyze the bacterial load in the organs of infected mice and
also to analyze the ability of different strains of S. enterica to
multiply inside macrophages and in the presence of mouse serum.
Supporting Information
Table S1 List of genes which are down-regulated in the strain
having pTrc99A but not in the strain having pTrc(-LacI)
Found at: doi:10.1371/journal.pone.0005789.s001 (0.16 MB
DOC)
Table S2 List of genes which are up-regulated in the strain
having pTrc99A but not in the strain having pTrc(-LacI)
Found at: doi:10.1371/journal.pone.0005789.s002 (0.30 MB
DOC)
Table S3 Plasmid constructs used in this study
Found at: doi:10.1371/journal.pone.0005789.s003 (0.03 MB
DOC)
Table S4 Primers used in this study
Found at: doi:10.1371/journal.pone.0005789.s004 (0.03 MB
DOC)
Table S5 Raw data of microarray experiment
Found at: doi:10.1371/journal.pone.0005789.s005 (8.59 MB
XLS)
Figure S1 Analysis of expression of LacI. (A) RT-PCR analysis
of lacI expression in different strains of Salmonella and E. coli.
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RNase-free DNase and reverse transcribed. cDNA thus generated
was used for PCR amplification. (B) PCR amplification of lacI
from the genomic DNA of bacteria. In both (A) and (B), PCR was
done using lacI-specific primers. rpoD was used as internal
control. (C) Western blot analysis of LacI expression in different
strains of Salmonella. Equal number of bacteria from overnight
culture was lysed and the lysate was used for Western blot analysis.
LacI antibody was from Abcam.
Found at: doi:10.1371/journal.pone.0005789.s006 (1.24 MB TIF)
Figure S2 Effect of LacI on the proliferation of Salmonella in
mice infected via intra-gastric route. The graph shows the
bacterial load of the spleens of mice infected with Salmonella.
Found at: doi:10.1371/journal.pone.0005789.s007 (8.43 MB TIF)
Figure S3 Expression of LacI in Salmonella does not affect
invasion. HeLa cells were infected as described in Materials and
Methods with log-phase bacteria with an MOI of 1. Cells were
lysed at 1 h after infection to recover the intracellular bacteria.
Percentage of entry was calculated by comparing the number of
entered bacteria with the number of bacteria in the pre-inoculum.
Found at: doi:10.1371/journal.pone.0005789.s008 (8.43 MB TIF)
Figure S4 LacI interferes with SPI-2 expression inside macro-
phages. The effect of LacI on the expression of virulence genes was
analyzed by quantitative real-time PCR. The cDNA was
synthesized from the RNA isolated from intracellular bacteria
and was used to perform quantitative real-time PCR using
DyNAmo
TM HS SYBRH Green qPCR Kit. Following conditions
were used for all reactions: 40 cycles of 94uC for 20 sec, 57uC for
30 sec and 72uC for 30 sec. Relative amounts of ssaK, sseB and
phoP mRNA with respect to rpoD mRNA was quantified.
Found at: doi:10.1371/journal.pone.0005789.s009 (8.43 MB TIF)
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